TRACON Pharmaceuticals Shares Outstanding 2013-2021 | TCON

TRACON Pharmaceuticals shares outstanding from 2013 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
TRACON Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2020 9
2019 3
2018 3
2017 2
2016 1
2015 1
2014 0
2013 0
2012 0
TRACON Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 15
2021-03-31 15
2020-12-31 9
2020-09-30 11
2020-06-30 6
2020-03-31 5
2019-12-31 3
2019-09-30 3
2019-06-30 3
2019-03-31 3
2018-12-31 3
2018-09-30 3
2018-06-30 3
2018-03-31 2
2017-12-31 2
2017-09-30 2
2017-06-30 2
2017-03-31 2
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 1
2015-09-30 1
2015-06-30 1
2015-03-31 1
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.084B $0.003B
TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71